Emicizumab-induced photosensitivity.

Authors :: Asensi Cantó P
Rodríguez Serna M
Lloret Madrid P
Solís Ruiz J
Cid Haro AR
Bonanad Boix S
Haya Guaita S
Source :: TH open : companion journal to thrombosis and haemostasis [TH Open] 2022 Jul 21; Vol. 6 (3), pp. e154-e155. Date of Electronic Publication: 2022 Jul 21 (Print Publication: 2022).
Publication Year :: 2022
Abstract: Emicizumab constitutes a novel and effective prophylaxis for hemophilia A patients with and without inhibitors. In this case report, we describe an emicizumab-induced photosensitivity that forced permanent sun-exposure suppression. To the best of our knowledge, this side effect had not been communicated until present.<br />Competing Interests: Conflict of Interest None declared.<br /> (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ).)